Author

Scott D. Taylor

University of California, Los AngelesORCID 0000-0001-6767-864XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Aaron S. MeyeriD· 3 shared Michelle Loui· 2 shared Allison Brookhart· 1 shared Brian T. Orcutt-JahnsiD· 1 shared Carmen Boixo· 1 shared Eli M. SnyderiD· 1 shared Forest M. WhiteiD· 1 shared Gabriella DiBernardoiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Aaron S. MeyerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 29, 2026

Systems serology of responses against tumor antigens in ovarian cancer reveal disrupted Fc-mediated immunity

Michelle Loui, Meera Trisal, Laura B. James‐Allan…·Aaron S. Meyer

This study identifies tumor-binding autoantibodies in ovarian cancer patients that fail to engage Fc{gamma}RIIIa, impairing antibody-dependent cellular cytotoxicity.

DOI 10.64898/2026.04.25.720834

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 20, 2023

Dissecting signaling regulators driving AXL-mediated bypass resistance and associated phenotypes by phosphosite perturbations

Marc Creixell, Scott D. Taylor, Jacqueline S. Gerritsen…·Aaron S. Meyer

The paper uses phosphosite perturbations to identify signaling pathways driving AXL-mediated erlotinib resistance in lung cancer.

1 citation

humanproteomics

𝕏 PostBluesky

Systems BiologybioRxivPreprintJul 3, 2021

Multivalent, asymmetric IL-2-Fc fusions provide optimally enhanced regulatory T cell selectivity

Brian T. Orcutt-Jahns, Peter C. Emmel, Eli M. Snyder…·Aaron S. Meyer

This paper systematically evaluates IL-2-Fc fusions to enhance Treg selectivity by exploring valency, orientation, and binding kinetics, identifying multivalency and asymmetry as key factors for improved specificity.

2 citations

humanstatistical model

𝕏 PostBluesky